SEC Form 4 · accession 0001246360-15-002339
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean K Mixer
Director
Period of report
May 21, 2015
Accepted (ET)
May 26, 2015 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.81 | May 21, 2015 | A | 19,724 | A | Jun 21, 2015 | May 20, 2025 | Common Stock | 19,724 | 19,724 | D |
Explanation of responses
- F1The stock option becomes exercisable in 12 equal monthly installments beginning June 21, 2015.